Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Renal Transplant Recipient.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00658320
What this trial is testing

Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids

Who this might be right for
Kidney Transplantation
Novartis 122
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Large-scale testing (Phase 3)Study completedNCT01410448
What this trial is testing

Everolimus in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 383
Not applicableLooking for participantsNCT07081126
What this trial is testing

Daratumumab for Late Antibody-Mediated Rejection

Who this might be right for
Kidney TansplantAcute Rejection (AR) of Transplanted Kidney
University Hospital, Martin 20
Post-approval studies (Phase 4)UnknownNCT05872568
What this trial is testing

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Zhishui Chen 270
Not applicableEnded earlyNCT01609673
What this trial is testing

Study of Everolimus in de Novo Renal Transplant Recipients

Who this might be right for
End Stage Renal Failure With Renal Transplant
Helady Pinheiro, MD, PhD 1
Large-scale testing (Phase 3)Study completedNCT00098241
What this trial is testing

Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 45
Post-approval studies (Phase 4)Study completedNCT00170885
What this trial is testing

Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis
Post-approval studies (Phase 4)Study completedNCT00229138
What this trial is testing

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 291
Post-approval studies (Phase 4)Ended earlyNCT00522548
What this trial is testing

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

Who this might be right for
Transplants and Implants
University of Pennsylvania 37
Large-scale testing (Phase 3)Study completedNCT00239863
What this trial is testing

Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Large-scale testing (Phase 3)Study completedNCT00531063
What this trial is testing

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 237
Testing effectiveness (Phase 2)Ended earlyNCT00555789
What this trial is testing

24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 137
Post-approval studies (Phase 4)UnknownNCT03828682
What this trial is testing

Veloxis de Novo Kidney Transplant ECSWD

Who this might be right for
Kidney TransplantationImmunosuppression
Simon Tremblay, PharmD, PhD 60
Large-scale testing (Phase 3)Study completedNCT02005562
What this trial is testing

OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 252
Large-scale testing (Phase 3)Study completedNCT00531440
What this trial is testing

This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 256
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Post-approval studies (Phase 4)Study completedNCT00195481
What this trial is testing

Study Evaluating Sirolimus in Kidney Transplant Recipients in India

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 100
Testing effectiveness (Phase 2)Study completedNCT02217410
What this trial is testing

CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 59
Post-approval studies (Phase 4)Active Not RecruitingNCT03797196
What this trial is testing

RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients

Who this might be right for
Renal Transplant RecipientsElderly PatientsImmunosuppression
University Medical Center Groningen 374
Next Page